Real ChatGPT answer · index seed8D7DIAyDB5EcompleteHealth and wellness · women's healthinformational
Could you explain the latest FDA guidelines regarding the safety profile of bioidentical hormone replacement therapy for women over sixty who suffer from debilitating hot flashes?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Could you explain the latest FDA guidelines regarding the safety profile of bioidentical hormone replacement therapy for women over sixty who suffer from debilitating hot flashes?
3 real searches · 1 real-search pass
FDA latest guidance bioidentical hormone therapy compounded menopausal hormone therapy women over 60 2026 FDA labeling safety hot flashesGoogle ↗
OBSERVEDOther / navigational
FDA menopausal hormone therapy boxed warning labeling update 2025 2026 official FDAGoogle ↗
OBSERVEDConsequence
NAMS menopause hormone therapy women older than 60 initiation risks official position statementGoogle ↗
OBSERVEDConsequence
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (3)
Classes come from the query-classifier (a local Laya model). 3 of 3 calls are low-confidence (under 50%) — hover a query in the table to see its confidence.
Searches and sources
ChatGPT3 real searches · gpt-6
FDA latest guidance bioidentical hormone therapy compounded menopausal hormone therapy women over 60 2026 FDA labeling safety hot flashes Google ↗
FDA menopausal hormone therapy boxed warning labeling update 2025 2026 official FDA Google ↗
NAMS menopause hormone therapy women older than 60 initiation risks official position statement Google ↗
- FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies · fda.gov
- FDA Approves Labeling Changes to Menopausal Hormone Therapy Products · fda.gov
- Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms · fda.gov
- The 2022 hormone therapy position statement of The North American Menopause Society · pubmed.ncbi.nlm.nih.gov
- VA/DOD CLINICAL PRACTICE GUIDELINE FOR MENOPAUSE · healthquality.va.gov
- Hormone therapy safety · womenshealth.gov
- Menopause · fda.gov
- Compounded Bioidentical Menopausal Hormone Therapy · albme.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
FDA latest guidance bioidentical hormone therapy compounded menopausal hormone therapy women over 60 2026 FDA labeling safety hot flashes OBSERVED | Google ↗ AI Mode ↗ | — | Other / navigational | — | — | 1x of 1 | |
FDA menopausal hormone therapy boxed warning labeling update 2025 2026 official FDA OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 | |
NAMS menopause hormone therapy women older than 60 initiation risks official position statement OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 |